Status:
COMPLETED
Daily ECG Versus 7-day Holter ECG After Atrial Fibrillation Ablation
Lead Sponsor:
Centre of Postgraduate Medical Education
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Introduction: The optimal method for the assessment of efficacy of ablation for atrial fibrillation (AF) has not yet been established. The symptom-based evaluation is not accurate because many AF epi...
Detailed Description
Daily ECG transmission versus serial 7-day Holter ECG for assessment of efficacy of ablation for atrial fibrillation - the AGNES-ECG study Introduction. The optimal method for the assessment of effic...
Eligibility Criteria
Inclusion
- AF ablation 1-3 days prior to inclusion
- Access to smartphone and ability to maintain ISTEL recorder and transmitting ECG.
Exclusion
- Pacemaker implanted.
- Known presence of other than AF cardiac arrhythmias requiring frequent ECG monitoring (ventricular arrhythmia, second or third-degree atrioventricular block)
- Lack of smartphone or inability to manage ISTEL recorder.
Key Trial Info
Start Date :
August 27 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2021
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT03877913
Start Date
August 27 2018
End Date
May 30 2021
Last Update
March 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre of Postgraduate Medical Education
Warsaw, Masovian Voivodeship, Poland, 01-813